BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35811230)

  • 1. Age-associated differences in the cancer molecular landscape.
    Chatsirisupachai K; Lagger C; de Magalhães JP
    Trends Cancer; 2022 Nov; 8(11):962-971. PubMed ID: 35811230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The genomic landscape of breast cancer and its interaction with host immunity.
    Luen S; Virassamy B; Savas P; Salgado R; Loi S
    Breast; 2016 Oct; 29():241-50. PubMed ID: 27481651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pan-cancer analysis reveals molecular patterns associated with age.
    Shah Y; Verma A; Marderstein AR; White J; Bhinder B; Garcia Medina JS; Elemento O
    Cell Rep; 2021 Dec; 37(10):110100. PubMed ID: 34879281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revisiting the Genomic and Transcriptomic Landscapes from Female Malignancies Could Provide Molecular Markers and Targets for Precision Medicine.
    Taniguchi-Ponciano K; Huerta-Padilla V; Baeza-Xochihua V; Ponce-Navarrete G; Salcedo E; Gomez-Apo E; Chavez-Macias L; Aviles-Duran J; Ruiz-Sanchez H; Valdivia A; Peralta R; Romero-Anduaga H; Rosas-Vargas H; Quijano F; Salcedo M; Marrero-Rodríguez D
    Arch Med Res; 2019 Oct; 50(7):428-436. PubMed ID: 31783305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Pan-cancer Landscape of Interactions between Solid Tumors and Infiltrating Immune Cell Populations.
    Tamborero D; Rubio-Perez C; Muiños F; Sabarinathan R; Piulats JM; Muntasell A; Dienstmann R; Lopez-Bigas N; Gonzalez-Perez A
    Clin Cancer Res; 2018 Aug; 24(15):3717-3728. PubMed ID: 29666300
    [No Abstract]   [Full Text] [Related]  

  • 6. Changing Landscape of Clinical-Genomic Oncology Practice.
    Trivedi H; Kling HM; Treece T; Audeh W; Srkalovic G
    Acta Med Acad; 2019 Apr; 48(1):6-17. PubMed ID: 31264429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in computational approaches for prioritizing driver mutations and significantly mutated genes in cancer genomes.
    Cheng F; Zhao J; Zhao Z
    Brief Bioinform; 2016 Jul; 17(4):642-56. PubMed ID: 26307061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of extrahepatic cholangiocarcinoma: perihilar and distal tumors display divergent genomic and transcriptomic profiles.
    Simbolo M; Bersani S; Vicentini C; Taormina SV; Ciaparrone C; Bagante F; Rusev B; Centonze G; Montresor M; Brunelli M; Pedron S; Mafficini A; Paolino G; Mattiolo P; Conci S; Milione M; Guglielmi A; Ruzzenente A; Scarpa A; Luchini C
    Expert Opin Ther Targets; 2021 Dec; 25(12):1095-1105. PubMed ID: 34873971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer genomics: from discovery science to personalized medicine.
    Chin L; Andersen JN; Futreal PA
    Nat Med; 2011 Mar; 17(3):297-303. PubMed ID: 21383744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic Analysis of Childhood Brain Tumors: Methods for Genome-Wide Discovery and Precision Medicine Become Mainstream.
    Mack SC; Northcott PA
    J Clin Oncol; 2017 Jul; 35(21):2346-2354. PubMed ID: 28640705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The genomic landscape of pediatric acute lymphoblastic leukemia and precision medicine opportunities.
    Tran TH; Hunger SP
    Semin Cancer Biol; 2022 Sep; 84():144-152. PubMed ID: 33197607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Key Lessons Learned from Moffitt's Molecular Tumor Board: The Clinical Genomics Action Committee Experience.
    Knepper TC; Bell GC; Hicks JK; Padron E; Teer JK; Vo TT; Gillis NK; Mason NT; McLeod HL; Walko CM
    Oncologist; 2017 Feb; 22(2):144-151. PubMed ID: 28179575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploiting rare driver mutations for precision cancer medicine.
    Scholl C; Fröhling S
    Curr Opin Genet Dev; 2019 Feb; 54():1-6. PubMed ID: 30844512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
    Paolillo C; Londin E; Fortina P
    Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissection of gastric cancer heterogeneity for precision oncology.
    Ho SWT; Tan P
    Cancer Sci; 2019 Nov; 110(11):3405-3414. PubMed ID: 31495054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precision Medicine in Pediatric Oncology: Translating Genomic Discoveries into Optimized Therapies.
    Tran TH; Shah AT; Loh ML
    Clin Cancer Res; 2017 Sep; 23(18):5329-5338. PubMed ID: 28600472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular imaging of the tumor microenvironment for precision medicine and theranostics.
    Penet MF; Krishnamachary B; Chen Z; Jin J; Bhujwalla ZM
    Adv Cancer Res; 2014; 124():235-56. PubMed ID: 25287691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer biology deciphered by single-cell transcriptomic sequencing.
    Li Y; Jin J; Bai F
    Protein Cell; 2022 Mar; 13(3):167-179. PubMed ID: 34405376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How Genetics and Genomics Advances Are Rewriting Pediatric Cancer Research and Clinical Care.
    Cipri S; Abenavoli L; Boccuto L; Del Baldo G; Mastronuzzi A
    Medicina (Kaunas); 2022 Oct; 58(10):. PubMed ID: 36295546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrative analysis of genomic and transcriptomic characteristics associated with progression of aggressive thyroid cancer.
    Yoo SK; Song YS; Lee EK; Hwang J; Kim HH; Jung G; Kim YA; Kim SJ; Cho SW; Won JK; Chung EJ; Shin JY; Lee KE; Kim JI; Park YJ; Seo JS
    Nat Commun; 2019 Jun; 10(1):2764. PubMed ID: 31235699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.